Evidence map›Paper›PMID 42846808›Full record

ReviewFrontiers in aging neuroscience2026

Peroxisomes in Alzheimer's disease: emerging mechanistic insights and therapeutic opportunities.

Tao Liu, Yiran Liu, Yichi Zhang, Jin Wang, Yulin Ren, Shujun Fu, Li Han, Pengcheng Jiang, Jie Chen, Yuanzhi Li and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tao Liu *Department of Pathophysiology, School of Basic Medical Sciences, Hunan Normal University, Changsha, China.
Yiran Liu *Key Laboratory of Model Animals and Stem Cell Biology in Hunan Province, Hunan Normal University, Health Science Center, Changsha, Hunan, China.
Yichi ZhangDepartment of Physiology, School of Basic Medical Sciences, Hunan Normal University, Changsha, China.
Jin WangDepartment of Physiology, School of Basic Medical Sciences, Hunan Normal University, Changsha, China.
Yulin RenDepartment of Physiology, School of Basic Medical Sciences, Hunan Normal University, Changsha, China.
Shujun FuDepartment of Pathophysiology, School of Basic Medical Sciences, Hunan Normal University, Changsha, China.
Li HanHunan Provincial Key Laboratory of New Pharmaceutical Preparation, Changsha Medical University, Changsha, Hunan, China.
Pengcheng JiangHunan Provincial Key Laboratory of New Pharmaceutical Preparation, Changsha Medical University, Changsha, Hunan, China.
Jie ChenDepartment of Physiology, School of Basic Medical Sciences, Hunan Normal University, Changsha, China.
Yuanzhi LiDepartment of Neurosurgery, Affiliated Hengyang Hospital of Hunan Normal University and Hengyang Central Hospital, Hengyang, Hunan, China.
Huaiqing LuoDepartment of Pathophysiology, School of Basic Medical Sciences, Hunan Normal University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is characterized by amyloid-

Indexed as

Alzheimer’s diseaselipid metabolismmitochondrianeuroinflammationoxidative stressperoxisomePPAR

Identifiers

PMID42846808
PMCPMC13643710

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.